Form 8-K - Current report:
SEC Accession No. 0001683168-24-008403
Filing Date
2024-11-26
Accepted
2024-11-26 17:26:02
Documents
16
Period of Report
2024-11-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cannabisbio_8k.htm   iXBRL 8-K 30248
2 DIRECTOR AGREEMENT cannabisbio_ex1001.htm EX-10.1 45603
3 NONDISCLOSURE / NONCIRCUMVENT AGREEMENT cannabisbio_ex1002.htm EX-10.2 29126
7 GRAPHIC image_003.jpg GRAPHIC 15356
  Complete submission text file 0001683168-24-008403.txt   321470

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cbih-20241122.xsd EX-101.SCH 3003
5 XBRL LABEL FILE cbih-20241122_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE cbih-20241122_pre.xml EX-101.PRE 24157
18 EXTRACTED XBRL INSTANCE DOCUMENT cannabisbio_8k_htm.xml XML 3489
Mailing Address 6201 BONHOMME ROAD SUITE 435S HOUSTON TX 77036
Business Address 6201 BONHOMME ROAD SUITE 435S HOUSTON TX 77036 214-733-0868
Cannabis Bioscience International Holdings, Inc. (Filer) CIK: 0001411057 (see all company filings)

EIN.: 844901229 | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 333-146758 | Film No.: 241505466
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)